Anúncio
Anúncio

TMO

TMO logo

Thermo Fisher Scientific, Inc.

619.05
USD
Patrocinado
+12.55
+2.07%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

608.35

-10.70
-1.73%

Relatórios de Lucros TMO

Rácio de surpresa positiva

TMO separação 33 de 39 últimas estimativas.

85%

Próximo Relatório

Data do Próximo Relatório
29 de jan. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$12.07B
/
$6.51
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+8.55%
/
+12.44%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+5.95%
/
+6.72%

Thermo Fisher Scientific, Inc. earnings per share and revenue

On 22 de out. de 2025, TMO reported earnings of 5.79 USD per share (EPS) for Q3 25, beating the estimate of 5.54 USD, resulting in a 4.37% surprise. Revenue reached 11.12 bilhão, compared to an expected 11.02 bilhão, with a 0.96% difference. The market reacted with a +1.65% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 analistas forecast an EPS of 6.51 USD, with revenue projected to reach 12.07 bilhão USD, implying an aumentar of 12.44% EPS, and aumentar of 8.55% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06 de jan. de 2026 Para Q2 26
Estimativa
-$0.10
Real
$0.00
Surpresa
+100.00%
FAQ
For Q3 2025, Thermo Fisher Scientific, Inc. reported EPS of $5.79, beating estimates by 4.37%, and revenue of $11.12B, 0.96% above expectations.
The stock price moved up 1.65%, changed from $557.99 before the earnings release to $567.20 the day after.
The next earning report is scheduled for 29 de jan. de 2026.
Based on 22 analistas, Thermo Fisher Scientific, Inc. is expected to report EPS of $6.51 and revenue of $12.07B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio